In addition, in breast cancer, IL-8 (interleukin-8) secretion following JAK2/STAT5 (Janus kinase 2/signal transducer and activator of transcription 5) activation has also been shown to counteract the anticancer efficacy of PI3K inhibitors [42]. This evidence concerns the gene PIK3CD and breast cancer.